These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 30502844)

  • 21. Thromboprophylaxis With Apixaban in Patients Undergoing Major Orthopedic Surgery: Meta-Analysis and Trial-Sequential Analysis.
    Caldeira D; Rodrigues FB; Pinto FJ; Ferreira JJ; Costa J
    Clin Med Insights Blood Disord; 2017; 10():1179545X17704660. PubMed ID: 28579855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Bates SM; Greer IA; Pabinger I; Sofaer S; Hirsh J
    Chest; 2008 Jun; 133(6 Suppl):844S-886S. PubMed ID: 18574280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TropicALL study: Thromboprophylaxis in Children treated for Acute Lymphoblastic Leukemia with Low-molecular-weight heparin: a multicenter randomized controlled trial.
    Klaassen ILM; Lauw MN; van de Wetering MD; Biemond BJ; Middeldorp S; Abbink FCH; Bierings M; Te Loo DMMW; Pieters R; van der Sluis IM; Tissing WJE; Michel Zwaan C; Heleen van Ommen C
    BMC Pediatr; 2017 May; 17(1):122. PubMed ID: 28486976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meta-Analysis Comparing the Efficacy, Safety, and Cost-Benefit of Direct Acting Oral Anticoagulants Versus Enoxaparin Thromboprophylaxis to Prevent Venous Thromboembolism Among Hospitalized Patients.
    Bhalla V; Abdel-Latif A; Bhalla M; Ziada K; Williams MV; Smyth SS
    Am J Cardiol; 2018 Oct; 122(7):1236-1243. PubMed ID: 30082040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Real-life practices for preventing venous thromboembolism in multiple myeloma patients: a cohort study from the French health insurance database.
    Palmaro A; Rougé-Bugat ME; Gauthier M; Despas F; Moulis G; Lapeyre-Mestre M
    Pharmacoepidemiol Drug Saf; 2017 May; 26(5):578-586. PubMed ID: 28198064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thromboprophylaxis for patients at high risk of VTE.
    Mackenzie DG; Elders A; Wild S; Muir R
    Lancet; 2008 Jun; 371(9628):1911; author reply 1912-3. PubMed ID: 18539216
    [No Abstract]   [Full Text] [Related]  

  • 27. [Newly diagnosed multiple myeloma: Do we need to propose thromboprophylaxis?].
    Chalayer E; Augeul-Meunier K; Tardy-Poncet B; Cathebras P; Guyotat D; Tardy B
    Rev Med Interne; 2012 Dec; 33(12):693-6. PubMed ID: 23067869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters.
    Schoot RA; Kremer LC; van de Wetering MD; van Ommen CH
    Cochrane Database Syst Rev; 2013 Sep; (9):CD009160. PubMed ID: 24026801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Administration of Aspirin as a Prophylaxis Agent Against Venous Thromboembolism Results in Lower Incidence of Periprosthetic Joint Infection.
    Huang R; Buckley PS; Scott B; Parvizi J; Purtill JJ
    J Arthroplasty; 2015 Sep; 30(9 Suppl):39-41. PubMed ID: 26182982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of Venous Thromboembolism after Arthroscopic Knee Surgery in a Low-Risk Population with the Use of Aspirin. A Randomized Trial.
    Kaye ID; Patel DN; Strauss EJ; Alaia MJ; Garofolo G; Martinez A; Jazrawi LM
    Bull Hosp Jt Dis (2013); 2015 Dec; 73(4):243-8. PubMed ID: 26630467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma.
    Palumbo A; Rajkumar SV; Dimopoulos MA; Richardson PG; San Miguel J; Barlogie B; Harousseau J; Zonder JA; Cavo M; Zangari M; Attal M; Belch A; Knop S; Joshua D; Sezer O; Ludwig H; Vesole D; Bladé J; Kyle R; Westin J; Weber D; Bringhen S; Niesvizky R; Waage A; von Lilienfeld-Toal M; Lonial S; Morgan GJ; Orlowski RZ; Shimizu K; Anderson KC; Boccadoro M; Durie BG; Sonneveld P; Hussein MA;
    Leukemia; 2008 Feb; 22(2):414-23. PubMed ID: 18094721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple myeloma, venous thromboembolism, and treatment-related risk of thrombosis.
    Zamagni E; Brioli A; Tacchetti P; Zannetti B; Pantani L; Cavo M
    Semin Thromb Hemost; 2011 Apr; 37(3):209-19. PubMed ID: 21455855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of pharmacologic prophylaxis in prevention of venous thromboembolism following total knee arthroplasty.
    Richardson SS; Schairer WW; Sculco PK; Bostrom MP
    Knee; 2019 Mar; 26(2):451-458. PubMed ID: 30700390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aspirin and compression devices versus low-molecular-weight heparin and PCD for VTE prophylaxis in orthopedic oncology patients.
    Patel AR; Crist MK; Nemitz J; Mayerson JL
    J Surg Oncol; 2010 Sep; 102(3):276-81. PubMed ID: 20740587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thalidomide thromboprophylaxis in multiple myeloma: a review of current evidence.
    Alexander M; Kirsa S; Mellor JD
    Asia Pac J Clin Oncol; 2012 Dec; 8(4):319-24. PubMed ID: 22897571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Venous thromboembolism in cancer patients - risk scores and recent randomised controlled trials.
    Thaler J; Ay C; Pabinger I
    Thromb Haemost; 2012 Dec; 108(6):1042-8. PubMed ID: 22836491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence and prophylaxis of venous thromboembolic events in multiple myeloma patients receiving immunomodulatory therapy.
    Musallam KM; Dahdaleh FS; Shamseddine AI; Taher AT
    Thromb Res; 2009 Mar; 123(5):679-86. PubMed ID: 18992924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct oral anticoagulants versus aspirin for primary thromboprophylaxis in patients with multiple myeloma undergoing outpatient therapy: A systematic review and updated meta-analysis.
    Costa TA; Felix N; Costa BA; Godoi A; Nogueira A; Rossi A
    Br J Haematol; 2023 Nov; 203(3):395-403. PubMed ID: 37533165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness of prolonged thromboprophylaxis after cancer surgery.
    Bradley CT; Brasel KJ; Miller JJ; Pappas SG
    Ann Surg Oncol; 2010 Jan; 17(1):31-9. PubMed ID: 19707830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prophylactic recombinant erythropoietin therapy and thalidomide are predictors of venous thromboembolism in patients with multiple myeloma: limited effectiveness of thromboprophylaxis.
    Anaissie EJ; Coleman EA; Goodwin JA; Kennedy RL; Lockhart KD; Stewart CB; Coon SK; Bailey C; Barlogie B
    Cancer; 2012 Jan; 118(2):549-57. PubMed ID: 21720994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.